Heptares’ technology highlighted in journal

Friday 27 January 2012

Two papers in the Journal of Medicinal Chemistry have highlighted technology developed by scientists at Heptares Therapeutics Ltd aimed at generating new leads for drugs that target the G protein-coupled receptor (GPCR) family of proteins.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom